Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 343 entries
Sorted by: Best Match Show Resources per page
MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma.

Oncotarget

Pillar N, Bairey O, Goldschmidt N, Fellig Y, Rosenblat Y, Shehtman I, Haguel D, Raanani P, Shomron N, Siegal T.
PMID: 29156774
Oncotarget. 2017 Sep 15;8(49):86020-86030. doi: 10.18632/oncotarget.20902. eCollection 2017 Oct 17.

Systemic diffuse large B-cell lymphoma (DLBCL) is a potentially curable disease using current regimen of immunochemotherapy. Central nervous system (CNS) relapse is a complication that occurs in approximately 5% of DLBCL patients and is associated with a high fatality...

Cite
Pillar N, Bairey O, Goldschmidt N, et al. MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma. Oncotarget. 2017;8(49):86020-86030doi: 10.18632/oncotarget.20902.
Pillar, N., Bairey, O., Goldschmidt, N., Fellig, Y., Rosenblat, Y., Shehtman, I., Haguel, D., Raanani, P., Shomron, N., & Siegal, T. (2017). MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma. Oncotarget, 8(49), 86020-86030. https://doi.org/10.18632/oncotarget.20902
Pillar, Nir, et al. "MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma." Oncotarget vol. 8,49 (2017): 86020-86030. doi: https://doi.org/10.18632/oncotarget.20902
Pillar N, Bairey O, Goldschmidt N, Fellig Y, Rosenblat Y, Shehtman I, Haguel D, Raanani P, Shomron N, Siegal T. MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma. Oncotarget. 2017 Sep 15;8(49):86020-86030. doi: 10.18632/oncotarget.20902. eCollection 2017 Oct 17. PMID: 29156774; PMCID: PMC5689664.
Copy Download .nbib Format: NLM
Study to Predict Vascular Dysfunctions in High Risk Young Adults- An Immediate Non-Invasive Investigation to Prevent Early Vascular Ageing.

Journal of clinical and diagnostic research : JCDR

Manivel R, Ravanan P, Meenakshisundram C, Dhanaprakasam N, Sundramoorthy SA, Sreekumar S, Alagarsamy J, Amaladass A.
PMID: 26393120
J Clin Diagn Res. 2015 Jul;9(7):CC01-3. doi: 10.7860/JCDR/2015/12358.6146. Epub 2015 Jul 01.

INTRODUCTION: Normal vascular is associated with gradual change of vascular structure and function, resulting in increased arterial stiffening and decreased arterial compliance. Arterial stiffness is a marker of vascular ageing and a predictor of cardiovascular events. Premature or early...

Cite
Manivel R, Ravanan P, Meenakshisundram C, et al. Study to Predict Vascular Dysfunctions in High Risk Young Adults- An Immediate Non-Invasive Investigation to Prevent Early Vascular Ageing. J Clin Diagn Res. 2015;9(7):CC01-3doi: 10.7860/JCDR/2015/12358.6146.
Manivel, R., Ravanan, P., Meenakshisundram, C., Dhanaprakasam, N., Sundramoorthy, S. A., Sreekumar, S., Alagarsamy, J., & Amaladass, A. (2015). Study to Predict Vascular Dysfunctions in High Risk Young Adults- An Immediate Non-Invasive Investigation to Prevent Early Vascular Ageing. Journal of clinical and diagnostic research : JCDR, 9(7), CC01-3. https://doi.org/10.7860/JCDR/2015/12358.6146
Manivel, Rajajeyakumar, et al. "Study to Predict Vascular Dysfunctions in High Risk Young Adults- An Immediate Non-Invasive Investigation to Prevent Early Vascular Ageing." Journal of clinical and diagnostic research : JCDR vol. 9,7 (2015): CC01-3. doi: https://doi.org/10.7860/JCDR/2015/12358.6146
Manivel R, Ravanan P, Meenakshisundram C, Dhanaprakasam N, Sundramoorthy SA, Sreekumar S, Alagarsamy J, Amaladass A. Study to Predict Vascular Dysfunctions in High Risk Young Adults- An Immediate Non-Invasive Investigation to Prevent Early Vascular Ageing. J Clin Diagn Res. 2015 Jul;9(7):CC01-3. doi: 10.7860/JCDR/2015/12358.6146. Epub 2015 Jul 01. PMID: 26393120; PMCID: PMC4572950.
Copy Download .nbib Format: NLM
Characterization of a Laterally Oscillating Microresonator Operating in the Nonlinear Region.

Micromachines

Ramanan A, Teoh YX, Ma W, Ye W.
PMID: 30404303
Micromachines (Basel). 2016 Aug 02;7(8). doi: 10.3390/mi7080132.

Microresonators are popular structures used in a variety of applications. They generally operate in the linear region where the vibration amplitude is limited, thereby limiting the signal-to-noise ratio. The nonlinear vibration region, where amplitudes and, consequently, the signal-to-noise ratio...

Cite
Ramanan A, Teoh YX, Ma W, et al. Characterization of a Laterally Oscillating Microresonator Operating in the Nonlinear Region. Micromachines (Basel). 2016;7(8)doi: 10.3390/mi7080132.
Ramanan, A., Teoh, Y. X., Ma, W., & Ye, W. (2016). Characterization of a Laterally Oscillating Microresonator Operating in the Nonlinear Region. Micromachines, 7(8), . https://doi.org/10.3390/mi7080132
Ramanan, Aditya, et al. "Characterization of a Laterally Oscillating Microresonator Operating in the Nonlinear Region." Micromachines vol. 7,8 (2016). doi: https://doi.org/10.3390/mi7080132
Ramanan A, Teoh YX, Ma W, Ye W. Characterization of a Laterally Oscillating Microresonator Operating in the Nonlinear Region. Micromachines (Basel). 2016 Aug 02;7(8). doi: 10.3390/mi7080132. PMID: 30404303; PMCID: PMC6190295.
Copy Download .nbib Format: NLM
Canine Leishmaniosis Control through the Promotion of Preventive Measures Appropriately Adopted by Citizens.

Journal of parasitology research

Simonato G, Marchiori E, Marcer F, Ravagnan S, Danesi P, Montarsi F, Bononi C, Capelli G, Pietrobelli M, Cassini R.
PMID: 32685202
J Parasitol Res. 2020 Jun 27;2020:8837367. doi: 10.1155/2020/8837367. eCollection 2020.

Canine leishmaniosis (CanL) is a disease caused by the protist

Cite
Simonato G, Marchiori E, Marcer F, et al. Canine Leishmaniosis Control through the Promotion of Preventive Measures Appropriately Adopted by Citizens. J Parasitol Res. 2020;2020:8837367doi: 10.1155/2020/8837367.
Simonato, G., Marchiori, E., Marcer, F., Ravagnan, S., Danesi, P., Montarsi, F., Bononi, C., Capelli, G., Pietrobelli, M., & Cassini, R. (2020). Canine Leishmaniosis Control through the Promotion of Preventive Measures Appropriately Adopted by Citizens. Journal of parasitology research, 20208837367. https://doi.org/10.1155/2020/8837367
Simonato, Giulia, et al. "Canine Leishmaniosis Control through the Promotion of Preventive Measures Appropriately Adopted by Citizens." Journal of parasitology research vol. 2020 (2020): 8837367. doi: https://doi.org/10.1155/2020/8837367
Simonato G, Marchiori E, Marcer F, Ravagnan S, Danesi P, Montarsi F, Bononi C, Capelli G, Pietrobelli M, Cassini R. Canine Leishmaniosis Control through the Promotion of Preventive Measures Appropriately Adopted by Citizens. J Parasitol Res. 2020 Jun 27;2020:8837367. doi: 10.1155/2020/8837367. eCollection 2020. PMID: 32685202; PMCID: PMC7336234.
Copy Download .nbib Format: NLM
Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study.

Scientifica

Fuggetta MP, Migliorino MR, Ricciardi S, Osman G, Iacono D, Leone A, Lombardi A, Ravagnan G, Greco S, Remotti D, Romano MCP.
PMID: 30838155
Scientifica (Cairo). 2019 Jan 31;2019:9136249. doi: 10.1155/2019/9136249. eCollection 2019.

BACKGROUND: Severe skin rash is listed among important side effects of EGFR tyrosine kinase inhibitors. Polydatin (PD), a glycosylated polyphenol, is endowed with anti-inflammatory activity in human epidermal keratinocytes.OBJECTIVE: This study evaluated the effect of topical application of a...

Cite
Fuggetta MP, Migliorino MR, Ricciardi S, et al. Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study. Scientifica (Cairo). 2019;2019:9136249doi: 10.1155/2019/9136249.
Fuggetta, M. P., Migliorino, M. R., Ricciardi, S., Osman, G., Iacono, D., Leone, A., Lombardi, A., Ravagnan, G., Greco, S., Remotti, D., & Romano, M. C. P. (2019). Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study. Scientifica, 20199136249. https://doi.org/10.1155/2019/9136249
Fuggetta, Maria Pia, et al. "Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study." Scientifica vol. 2019 (2019): 9136249. doi: https://doi.org/10.1155/2019/9136249
Fuggetta MP, Migliorino MR, Ricciardi S, Osman G, Iacono D, Leone A, Lombardi A, Ravagnan G, Greco S, Remotti D, Romano MCP. Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study. Scientifica (Cairo). 2019 Jan 31;2019:9136249. doi: 10.1155/2019/9136249. eCollection 2019. PMID: 30838155; PMCID: PMC6374781.
Copy Download .nbib Format: NLM
Is intensive care unit mortality a valid survival outcome measure related to critical illness?.

Anaesthesia, critical care & pain medicine

Laupland KB, Ramanan M, Shekar K, Kirrane M, Clement P, Young P, Edwards F, Bushell R, Tabah A.
PMID: 34902631
Anaesth Crit Care Pain Med. 2021 Dec 10;41(1):100996. doi: 10.1016/j.accpm.2021.100996. Epub 2021 Dec 10.

RATIONALE: Use of death as an outcome of intensive care unit (ICU) admission may be biased by differential discharge decisions.OBJECTIVE: To determine the validity of ICU survival status as an outcome measure of all cause case-fatality.METHODS: A retrospective cohort...

Cite
Laupland KB, Ramanan M, Shekar K, et al. Is intensive care unit mortality a valid survival outcome measure related to critical illness?. Anaesth Crit Care Pain Med. 2021;41(1):100996doi: 10.1016/j.accpm.2021.100996.
Laupland, K. B., Ramanan, M., Shekar, K., Kirrane, M., Clement, P., Young, P., Edwards, F., Bushell, R., & Tabah, A. (2021). Is intensive care unit mortality a valid survival outcome measure related to critical illness?. Anaesthesia, critical care & pain medicine, 41(1), 100996. https://doi.org/10.1016/j.accpm.2021.100996
Laupland, Kevin B, et al. "Is intensive care unit mortality a valid survival outcome measure related to critical illness?." Anaesthesia, critical care & pain medicine vol. 41,1 (2021): 100996. doi: https://doi.org/10.1016/j.accpm.2021.100996
Laupland KB, Ramanan M, Shekar K, Kirrane M, Clement P, Young P, Edwards F, Bushell R, Tabah A. Is intensive care unit mortality a valid survival outcome measure related to critical illness?. Anaesth Crit Care Pain Med. 2021 Dec 10;41(1):100996. doi: 10.1016/j.accpm.2021.100996. Epub 2021 Dec 10. PMID: 34902631.
Copy Download .nbib Format: NLM
Longitudinal changes in behaviour, mood, and functional capacity in the primary progressive aphasia variants.

The European journal of neuroscience

Foxe D, Irish M, Ramanan S, Stark S, Cordato NJ, Burrell JR, Piguet O.
PMID: 34888957
Eur J Neurosci. 2021 Dec 09; doi: 10.1111/ejn.15557. Epub 2021 Dec 09.

Primary progressive aphasia (PPA) is a neurodegenerative clinical syndrome characterised by a progressive decline in speech and language functions. Deficits in behaviour, mood, and functional capacity are reported in PPA but are less well understood. This study examined the...

Cite
Foxe D, Irish M, Ramanan S, et al. Longitudinal changes in behaviour, mood, and functional capacity in the primary progressive aphasia variants. Eur J Neurosci. 2021;doi: 10.1111/ejn.15557.
Foxe, D., Irish, M., Ramanan, S., Stark, S., Cordato, N. J., Burrell, J. R., & Piguet, O. (2021). Longitudinal changes in behaviour, mood, and functional capacity in the primary progressive aphasia variants. The European journal of neuroscience, . https://doi.org/10.1111/ejn.15557
Foxe, David, et al. "Longitudinal changes in behaviour, mood, and functional capacity in the primary progressive aphasia variants." The European journal of neuroscience vol. (2021). doi: https://doi.org/10.1111/ejn.15557
Foxe D, Irish M, Ramanan S, Stark S, Cordato NJ, Burrell JR, Piguet O. Longitudinal changes in behaviour, mood, and functional capacity in the primary progressive aphasia variants. Eur J Neurosci. 2021 Dec 09; doi: 10.1111/ejn.15557. Epub 2021 Dec 09. PMID: 34888957.
Copy Download .nbib Format: NLM
Rise in children presenting with periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome during the COVID-19 pandemic.

Archives of disease in childhood

Ng KF, Morgan J, Cutts T, Duncan I, Roderick M, Ramanan A, Goenka A.
PMID: 34301620
Arch Dis Child. 2021 Dec;106(12):e49. doi: 10.1136/archdischild-2021-322792. Epub 2021 Jul 22.

No abstract available.

Cite
Ng KF, Morgan J, Cutts T, et al. Rise in children presenting with periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome during the COVID-19 pandemic. Arch Dis Child. 2021;106(12):e49doi: 10.1136/archdischild-2021-322792.
Ng, K. F., Morgan, J., Cutts, T., Duncan, I., Roderick, M., Ramanan, A., & Goenka, A. (2021). Rise in children presenting with periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome during the COVID-19 pandemic. Archives of disease in childhood, 106(12), e49. https://doi.org/10.1136/archdischild-2021-322792
Ng, Khuen Foong, et al. "Rise in children presenting with periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome during the COVID-19 pandemic." Archives of disease in childhood vol. 106,12 (2021): e49. doi: https://doi.org/10.1136/archdischild-2021-322792
Ng KF, Morgan J, Cutts T, Duncan I, Roderick M, Ramanan A, Goenka A. Rise in children presenting with periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome during the COVID-19 pandemic. Arch Dis Child. 2021 Dec;106(12):e49. doi: 10.1136/archdischild-2021-322792. Epub 2021 Jul 22. PMID: 34301620.
Copy Download .nbib Format: NLM
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection.

Nature medicine

Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, Hunt D, Mei XW, Dixon S, Zaccardi F, Khunti K, Watkinson P, Coupland CAC, Doidge J, Harrison DA, Ravanan R, Sheikh A, Robertson C, Hippisley-Cox J.
PMID: 34697502
Nat Med. 2021 Dec;27(12):2144-2153. doi: 10.1038/s41591-021-01556-7. Epub 2021 Oct 25.

Emerging reports of rare neurological complications associated with COVID-19 infection and vaccinations are leading to regulatory, clinical and public health concerns. We undertook a self-controlled case series study to investigate hospital admissions from neurological complications in the 28 days...

Cite
Patone M, Handunnetthi L, Saatci D, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144-2153doi: 10.1038/s41591-021-01556-7.
Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., Hunt, D., Mei, X. W., Dixon, S., Zaccardi, F., Khunti, K., Watkinson, P., Coupland, C. A. C., Doidge, J., Harrison, D. A., Ravanan, R., Sheikh, A., Robertson, C., & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature medicine, 27(12), 2144-2153. https://doi.org/10.1038/s41591-021-01556-7
Patone, Martina, et al. "Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection." Nature medicine vol. 27,12 (2021): 2144-2153. doi: https://doi.org/10.1038/s41591-021-01556-7
Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, Hunt D, Mei XW, Dixon S, Zaccardi F, Khunti K, Watkinson P, Coupland CAC, Doidge J, Harrison DA, Ravanan R, Sheikh A, Robertson C, Hippisley-Cox J. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021 Dec;27(12):2144-2153. doi: 10.1038/s41591-021-01556-7. Epub 2021 Oct 25. PMID: 34697502; PMCID: PMC8629105.
Copy Download .nbib Format: NLM
Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia.

Cardio-oncology (London, England)

Pasvolsky O, Leader A, Iakobishvili Z, Wasserstrum Y, Kornowski R, Raanani P.
PMID: 33530148
Cardiooncology. 2015 Dec 04;1(1):5. doi: 10.1186/s40959-015-0008-5.

Tyrosine kinase inhibitors (TKIs) have revolutionized the management and outcomes of chronic myeloid leukemia (CML) patients. Improved disease control and prolonged life expectancy now mandate focus on improving TKIs' safety profile. Recently, vascular adverse events (VAEs) have emerged as...

Cite
Pasvolsky O, Leader A, Iakobishvili Z, et al. Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia. Cardiooncology. 2015;1(1):5doi: 10.1186/s40959-015-0008-5.
Pasvolsky, O., Leader, A., Iakobishvili, Z., Wasserstrum, Y., Kornowski, R., & Raanani, P. (2015). Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia. Cardio-oncology (London, England), 1(1), 5. https://doi.org/10.1186/s40959-015-0008-5
Pasvolsky, Oren, et al. "Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia." Cardio-oncology (London, England) vol. 1,1 (2015): 5. doi: https://doi.org/10.1186/s40959-015-0008-5
Pasvolsky O, Leader A, Iakobishvili Z, Wasserstrum Y, Kornowski R, Raanani P. Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia. Cardiooncology. 2015 Dec 04;1(1):5. doi: 10.1186/s40959-015-0008-5. PMID: 33530148; PMCID: PMC7837152.
Copy Download .nbib Format: NLM
Is intensive care unit mortality a valid survival outcome measure related to critical illness?.

Anaesthesia, critical care & pain medicine

Laupland KB, Ramanan M, Shekar K, Kirrane M, Clement P, Young P, Edwards F, Bushell R, Tabah A.
PMID: 34902631
Anaesth Crit Care Pain Med. 2021 Dec 10;41(1):100996. doi: 10.1016/j.accpm.2021.100996. Epub 2021 Dec 10.

RATIONALE: Use of death as an outcome of intensive care unit (ICU) admission may be biased by differential discharge decisions.OBJECTIVE: To determine the validity of ICU survival status as an outcome measure of all cause case-fatality.METHODS: A retrospective cohort...

Cite
Laupland KB, Ramanan M, Shekar K, et al. Is intensive care unit mortality a valid survival outcome measure related to critical illness?. Anaesth Crit Care Pain Med. 2021;41(1):100996doi: 10.1016/j.accpm.2021.100996.
Laupland, K. B., Ramanan, M., Shekar, K., Kirrane, M., Clement, P., Young, P., Edwards, F., Bushell, R., & Tabah, A. (2021). Is intensive care unit mortality a valid survival outcome measure related to critical illness?. Anaesthesia, critical care & pain medicine, 41(1), 100996. https://doi.org/10.1016/j.accpm.2021.100996
Laupland, Kevin B, et al. "Is intensive care unit mortality a valid survival outcome measure related to critical illness?." Anaesthesia, critical care & pain medicine vol. 41,1 (2021): 100996. doi: https://doi.org/10.1016/j.accpm.2021.100996
Laupland KB, Ramanan M, Shekar K, Kirrane M, Clement P, Young P, Edwards F, Bushell R, Tabah A. Is intensive care unit mortality a valid survival outcome measure related to critical illness?. Anaesth Crit Care Pain Med. 2021 Dec 10;41(1):100996. doi: 10.1016/j.accpm.2021.100996. Epub 2021 Dec 10. PMID: 34902631.
Copy Download .nbib Format: NLM
Midterm results of homografts in pulmonary position: a retrospective single-center study.

Indian journal of thoracic and cardiovascular surgery

Raja J, Menon S, Sameer Mohammed, Ramanan S, Baruah SD, Gopalakrishnan A, Dharan BS.
PMID: 33642710
Indian J Thorac Cardiovasc Surg. 2021 Mar;37(2):129-137. doi: 10.1007/s12055-020-01065-1. Epub 2020 Nov 23.

OBJECTIVE: Valved conduits play a pivotal role in the right ventricular outflow tract (RVOT) reconstruction in patients with congenital heart disease (CHD), and valved homografts have become the most commonly used conduits in pediatric cardiac surgery. This study aimed...

Cite
Raja J, Menon S, Sameer Mohammed, et al. Midterm results of homografts in pulmonary position: a retrospective single-center study. Indian J Thorac Cardiovasc Surg. 2020;37(2):129-137doi: 10.1007/s12055-020-01065-1.
Raja, J., Menon, S., Sameer Mohammed, Ramanan, S., Baruah, S. D., Gopalakrishnan, A., & Dharan, B. S. (2021). Midterm results of homografts in pulmonary position: a retrospective single-center study. Indian journal of thoracic and cardiovascular surgery, 37(2), 129-137. https://doi.org/10.1007/s12055-020-01065-1
Raja, Javid, et al. "Midterm results of homografts in pulmonary position: a retrospective single-center study." Indian journal of thoracic and cardiovascular surgery vol. 37,2 (2021): 129-137. doi: https://doi.org/10.1007/s12055-020-01065-1
Raja J, Menon S, Sameer Mohammed, Ramanan S, Baruah SD, Gopalakrishnan A, Dharan BS. Midterm results of homografts in pulmonary position: a retrospective single-center study. Indian J Thorac Cardiovasc Surg. 2021 Mar;37(2):129-137. doi: 10.1007/s12055-020-01065-1. Epub 2020 Nov 23. PMID: 33642710; PMCID: PMC7876180.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 343 entries